2 weeks Ago By ABMN Staff
NKGen Biotech, Inc. ( NYSE:NKGN – Get Free Report )’s share price rose 1% during mid-day trading on Friday . The stock traded as high as $0.
82 and last traded at $0.77. Approximately 86,155 shares traded hands during mid-day trading, a decline of 95% from the average daily volume of 1,902,896 shares.
The stock had previously closed at $0.76. NKGen Biotech Stock Up 1.
0 % The company has a 50 day moving average price of $1.05 and a 200-day moving average price of $1.33.
Institutional Trading of NKGen Biotech A hedge fund recently bought a new stake in NKGen Biotech stock. University of Chicago purchased a new position in shares of NKGen Biotech, Inc. ( NYSE:NKGN – Free Report ) during the fourth quarter, according to its most recent 13F filing with the SEC.
The institutional investor purchased 550,000 shares of the company’s stock, valued at approximately $1,512,000. NKGen Biotech makes up 2.1% of University of Chicago’s holdings, making the stock its 5th largest holding.
University of Chicago owned approximately 2.51% of NKGen Biotech as of its most recent filing with the SEC. 76.
17% of the stock is owned by hedge funds and other institutional investors. About NKGen Biotech NKGen Biotech, Inc operates as a clinical-stage biotechnology company that focuses on the development and commercialization of autologous, allogeneic, and CAR-NK natural killer cell therapies. It develops SNK01, an autologous NK cell therapy; and SNK02, an allogeneic NK cell therapy, which are in Phase 1 clinical trials.
Recommended Stories Receive News & Ratings for NKGen Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NKGen Biotech and related companies with MarketBeat.com's FREE daily email newsletter ..
